✦ LIBER ✦

Growth factor (GF) augmentation of intensive chemotherapy for MDS and AML following MDS

✍ Scribed by Steven D. Gore; Philip J. Burke

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive chemotherapy of poor prognosis

✍ Tapani Ruutu; Auli Hänninen; Greta Järventie; Pirjo Koistinen; Elli Koivunen; Ka 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 599 KB

Outcome of High-Risk and Refractory AML/

✍ M. Detrait; P. Chevallier; M. Sobh; T. Guillaume; X. Thomas; S. Morisset; N. Ted 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Phase II Trial of Reduced Intensity Busu

✍ Chen, Yi-Bin; Li, Shuli; Del Rio, Candice; Coughlin, Erin; Ballen, Karen K.; Cut 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 124 KB

A multicenter, randomized trial of posac

✍ D.J. Winston; O.A. Cornely; J. Maertens; J. Perfect; D. Helfgott; A.J. Ullmann; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

High Rate Of De Novo Chronic Graft-Versu

✍ R.M. Saliba; K.V. Komanduri; E. Koca; A.M. Alousi; S. Giralt; B.S. Andersson; W. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

399 Cost-effectiveness of intensive adju

✍ P. Kellokumpu-Lehtinen 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB